BioCentury
ARTICLE | Emerging Company Profile

WindMIL: T cell source is key

WindMIL is harnessing marrow-derived T cells to develop cell therapies for cancer

February 26, 2020 9:26 PM UTC


Access this Article

BCIQ Company Profiles

WindMIL Therapeutics Inc.